Questions? Call a licensed agent: 1-866-340-3441

SCAN Venture (HMO) CY2027

Offered by SCAN Group (company name as listed by CMS) · Plan ID H5425-085-000 · Medicare Advantage with drug coverage

Available in 2027 in: 2 counties in California. See full service area

2027 Overall Star Rating: 4 out of 5 stars What star ratings mean

We do not offer every plan available in your area. Currently we represent 11 organizations which offer 45 products in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options. 1-800-MEDICARE (1-800-633-4227) is open 24 hours a day, 7 days a week. TTY users call 1-877-486-2048.

Medicare evaluates plans every year based on a 5-star rating system. Star Ratings shown are 2027 Star Ratings released by CMS on October 8, 2026.

This plan's 2027 documents

Summary of Benefits (PDF, carrier document, 2027)

The Summary of Benefits is the plan's own description of its costs and benefits. It comes from the plan company.

Key numbers from CMS files

Monthly plan premium
$0. You still pay your Part B premium.
Most you pay in-network in a year (MOOP)
$1,900
Drug deductible
$370
Part B giveback
$38 a month
Over-the-counter or benefit card
OTC allowance: $50 every 3 months
Extra benefits listed
Vision, OTC

These numbers come from CMS files. For what each benefit covers and costs, read the Summary of Benefits above. We do not write our own descriptions of plan benefits.

See all benefits
Eyewear, most the plan pays
$100 per year

Amounts are the most the plan pays, as listed in CMS benefit files.

Compared with 2026

Compared with SCAN Venture (HMO) (H5425-085-0), the 2026 plan.

2026 and 2027 values from CMS files
Item20262027
Monthly premium$0$0
Most you pay in-network (MOOP)$1,900$1,900
Drug deductible$250$370
Overall star rating4 out of 54 out of 5

Service area

California (2)

Riverside County, San Bernardino County

Compare this plan

Data used on this page

Researched and reviewed by , Licensed Insurance Agent, NPN 18910035, Senior Benefit Assistance. Last reviewed: November 11, 2026.